...
首页> 外文期刊>Cancer Cell International >Global expression profile of tumor stem-like cells isolated from MMQ rat prolactinoma cell
【24h】

Global expression profile of tumor stem-like cells isolated from MMQ rat prolactinoma cell

机译:从MMQ大鼠催乳素瘤细胞分离的肿瘤干样细胞的整体表达谱

获取原文
           

摘要

Cancer stem cells (CSCs), which have been isolated from various malignancies, were closely correlated with the occurrence, progression, metastasis and recurrence of the malignant cancer. Little is known about the tumor stem-like cells (TSLCs) isolated from benign tumors. Here we want to explore the global expression profile of RNA of tumor stem-like cells isolated from MMQ rat prolactinoma cells. In this study, total RNA was extracted from MMQ cells and MMQ tumor stem-like cells. RNA expression profiles were determined by Agilent Rat 8 × 60 K Microarray. Then we used the qRT-PCR to test the result of Microarray, and found VEGFA had a distinct pattern of expression in MMQ tumor stem-like cells. Then WB and ELISA were used to confirm the VEGFA protein level of tumor sphere cultured from both MMQ cell and human prolactinoma cell. Finally, CCK-8 was used to evaluate the reaction of MMQ tumor stem-like cells to small interfering RNAs intervention and bevacizumab treatment. The results of Microarray showed that 566 known RNA were over-expressed and 532 known RNA were low-expressed in the MMQ tumor stem-like cells. These genes were mainly involved in 15 different signaling pathways. In pathway in cancer and cell cycle, Bcl2, VEGFA, PTEN, Jun, Fos, APC2 were up-regulated and Ccna2, Cdc25a, Mcm3, Mcm6, Ccnb2, Mcm5, Cdk1, Gadd45a, Myc were down-regulated in the MMQ tumor stem-like cells. The expression of VEGFA were high in tumor spheres cultured from both MMQ cell and human prolactinomas. Down-regulation of VEGFA by small interfering RNAs partially decreased cell viability of MMQ tumor stem-like cells in vitro. Bevacizumab partially suppressed the proliferation of MMQ tumor stem-like cells. Our findings characterize the pattern of RNA expression of tumor stem-like cells isolated from MMQ cells. VEGFA may act as a potential therapeutic target for tumor stem-like cells of prolactinomas.
机译:从各种恶性肿瘤中分离出来的癌症干细胞(CSC)与恶性肿瘤的发生,进展,转移和复发密切相关。从良性肿瘤分离出的肿瘤干样细胞(TSLC)知之甚少。在这里,我们要探讨从MMQ大鼠催乳素瘤细胞中分离出来的肿瘤干样细胞RNA的全球表达谱。在这项研究中,从MMQ细胞和MMQ肿瘤干样细胞中提取了总RNA。 RNA表达谱通过Agilent Rat 8×60 K微阵列测定。然后我们使用qRT-PCR来测试微阵列的结果,发现VEGFA在MMQ肿瘤干样细胞中具有独特的表达模式。然后用WB和ELISA确定从MMQ细胞和人催乳素瘤细胞培养的肿瘤球的VEGFA蛋白水平。最后,CCK-8用于评估MMQ肿瘤干样细胞对小分子干扰RNA干预和贝伐单抗治疗的反应。微阵列的结果表明,在MMQ肿瘤干样细胞中566个已知RNA过度表达,而532个已知RNA低表达。这些基因主要参与15种不同的信号通路。在癌症和细胞周期的通路中,MMQ肿瘤干中的Bcl2,VEGFA,PTEN,Jun,Fos,APC2上调,而Ccna2,Cdc25a,Mcm3,Mcm6,Ccnb2,Mcm5,Cdk1,Gadd45a,Myc则下调。样细胞。在MMQ细胞和人催乳素瘤培养的肿瘤球中,VEGFA的表达很高。小型干扰RNA会下调VEGFA,从而部分降低MMQ肿瘤干样细胞的细胞活力。贝伐单抗部分抑制MMQ肿瘤干样细胞的增殖。我们的发现表征了从MMQ细胞分离的肿瘤干样细胞RNA表达的模式。 VEGFA可以作为催乳素瘤的肿瘤干样细胞的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号